연구동향 분석

방사성요오드(I-131) 격리병실 치료 관리를 위한 환자의 체외방사선량률과 상주 보호자의 피폭선량평가

강석진 이두현 소영 이정우 2022년

논문상세정보
인용/피인용
' 방사성요오드(I-131) 격리병실 치료 관리를 위한 환자의 체외방사선량률과 상주 보호자의 피폭선량평가' 의 주제별 논문영향력
논문영향력 선정 방법
논문영향력 요약
주제
  • Discharge Criteria
  • Exposure Dose
  • Humanoid Phantom
  • Isolation Ward
  • Radioisotope
  • i-131
  • 격리병실
  • 방사성동위원소
  • 방사성요오드
  • 인체모사팬텀
  • 퇴원기준
  • 피폭 선량
동일주제 총논문수 논문피인용 총횟수 주제별 논문영향력의 평균
173 0

0.0%

' 방사성요오드(I-131) 격리병실 치료 관리를 위한 환자의 체외방사선량률과 상주 보호자의 피폭선량평가' 의 참고문헌

  • 유리선량계를 이용한 CBCT의 유효선량 측정에 관한 연구
    문영민 [2013]
  • 방사선 개인피폭선량계를 이용한 피폭선량 측정 및 유용성 평가
    강인석 [2014]
  • 고용량 131I 투여환자 퇴원이후 환자 간병인과 환자 가옥의 피폭선량 측정
    정규환 [2010]
  • 갑상선암의 고용량 131I 치료 시 입원기간의 최적화방안 연구
    백성민 [2010]
  • Release of individuals containing unsealed byproduct material or implants containing byproduct material
  • Release of Patients After Radionuclide Therapy, with Contributions from the International Commission on Radiological Protection
    Agency IAE [2009]
  • Regulatory analysis on criteria for the release of patients administered radioactive material
    Schneider S [1994]
  • Radioiodine ablation following thyroidectomy for differentiated thyroid cancer : Literature review of utility, dose, and toxicity
    Andresen NS [2017]
  • Radioactivity MSC-oPitMoPWHRTAo. Management of radionuclide therapy patients
  • Radiation safety in the treatment of patients with thyroid diseases by radioiodine 131I : Practice recommendations of the American Thyroid Association
  • Radiation exposure from radioactive iodine I-131 in and surrounding the patients' room
  • Radiation exposure from outpatient radioactiveiodine(I-131)therapy for thyroid carcinoma
    Gringsby PW [2000]
  • Radiation exposure for 'caregivers' during high-dose outpatient radioiodine therapy
    Marriott CJ [2017]
  • Radiation Dose Assessment to Family Members Taking Care of Non-Cancerous Thyroid Patients Treated with I-131 Therapy in Nuclear Medicine Department
    Kadhim AA [2020]
  • Published on behalf of International Commission on Radiological Protection
  • Office of Federal and State Materials and Environmental Management Programs (FSME) Procedure Approval Reviewing the Non-Common Performance Indicator
  • Nuclear Safety Commission No. 19 Regulations on Technical Standards such as Radiation Safety Management
  • I-131 치료를 받은 분화갑상선암 환자에서 I-131의 유효반감기
    박석건 [2008]
  • Experimental and analytical dose assessment of patient's family members treated with I-131
    Ebrahimi M [2016]
  • Evaluation of the release criteria from hospital of thyroid carcinoma patient treated with 131I
    LahfiY [2016]
  • Could the treatment of differentiated thyroid carcinoma with 3.7 and 5.55 GBq of (I-131) Nal, on an outpatient basis, be safe?
  • Consolidated guidance about materials licenses. Program-Specific Guidance About Medical Use Licenses volume 9
    Howe DB [2008]
  • Comments regarding Practice Recommendations of the American Thyroid Association for radiation safety in the treatment of thyroid disease with radioiodine
  • Analysis of the caregiver effective dose during I-131 therapy of thyroid
    Taghavaee S [2018]